Fabio Pammolli

Fabio Pammolli (1965)


pammolli@gmail.com; f.pammolli@imtlucca.it


Full Professor of Economics and Management, University of Florence (on leave). Director, IMT Institute For Advanced Studies, Lucca, Italy (www.imtlucca.it) . Director, CERM (www.cermlab.it), Rome, Italy. Director, Ph.D program in Economics, Markets, Institutions, IMT Institute for Advanced Studies, Lucca, Italy.

Visiting Research Fellow Boston University, Center for Polymer Studies, Dept. of Physics, Boston (http://polymer.bu.edu/staff.html).

Publications and position papers on political economy and structural reforms in Italy and Europe are available at: www.cermlab.it.

Degree in Economics, University of Pisa; Graduate Studies, The Sant'Anna School of Advanced Studies (1989-1991). Visiting Research Fellow, Northeastern University (1990), Boston, Ma.; Visiting Scholar, Massachusetts Institute of Technology (1991, 1992), Boston, Ma.; Visiting Research Fellow, SCANCOR, Stanford University (2001), Stanford, Ca.

Pammolli's research deals with business firms growth, network evolution, the economic analysis of pharmaceutical, biotechnology and health care industries, the macroeconomics of health, as well as the interplay between institutional/regulatory variables and patterns of industrial dynamics.

He has published in journals such as: The Proceedings of the National Academy of Sciences (cover article, dec 27, 2005, vol. 102, n. 52), The Journal of the European Economics Association, The International Journal of Industrial Organization, Management Science, Physical Review E, Physica-A, Revue d'Economie Industrielle, Research Policy, Small Business Economics, Health Affairs, R&D Management, E. Journal of Health Economics, Europhysics Letters, Economics Letters, The European Physical Journal B.

Author, Global Competitiveness in Pharmaceuticals: A European Perspective, DG Enterprise, European Commission, 2001; Innovation and Competitiveness in European Biotechnology, DG Enterprise, European Commission, 2002; Medical Devices Competitiveness and Impact on Public Health Expenditure, DG Enterprise, European Commission, 2005; Pharmaceuticals, EU Competitiveness Report European Commission, Brussels, 2006; he contributed to the report on Public Health, Innovation and Intellectual Property Rights, Commission on Intellectual Property Rights, Innovation, and Public Health (CIPIH), World Health Organization. Member, Scientific Committee, National Institutes of Health, Rome Italy, 2001-6. Member, Pricing and Reimbursement Committee for Pharmaceutical Products, Italian Government, 1998-2008.

President, Siena Life Sciences Science Park, 1999-2001. Member, Commission on Intellectual Property Rights, Innovation, and Public Health (CIPIH), World Health Organization, Geneva, 2002-2006. Director, European Pharmaceutical Innovation and Regulation Systems (EPRIS).

He serves as an advisor of private multinational companies and foundations.

He has presented the findings of his research in seminars, conferences and given invited lectures at, among the others: National Bureau of Economic Research, London School of Economics, Massachusetts Institute of Technology, Stanford University, Columbia University, Berkeley University, the OECD, European Econometrics Society, Ecole de mines, Ecole Polytechnique, The Johns Hopkins University, the AAAS, the Council of Foreign Relations, The Royal Institute of International Affairs.



Fabio Pammolli's Recent Publications:

- F. Pammolli, 2009, "Patent Disclosure and R&D Competition in Pharmaceuticals", (with L. Magazzini, M. Riccaboni, M.A. Rossi), Economics of Innovation and New Technology, 18(5), 467–486

- F. Pammolli, 2009, "A Breath of Fresh Air? Firm Types, Scale, Scope and Selection Effects in Drug Development", (with A. Arora, A. Gambardella, L. Magazzini), Management Science, 55(10), 1638-1653

- F. Pammolli, 2008, "The Size Variance Relationship of Business Firm Growth Rates", (with S.V. Buldyrev, M. Riccaboni, H.E. Stanley, L. Ponta), Proceedings of the National Academy of Sciences, 195(50), 19563-20046

- F. Pammolli, 2008, "The Sustainability of European Health Care Systems: Beyond Income and Ageing", (with M. Riccaboni, L. Magazzini), working paper

- F. Pammolli, 2008, "Structure of Business Firm Networks and Scale-Free Models", (with M. Kitsak, M. Riccaboni, S. Havlin, H.E. Stanley), submitted to Physical Review E

- F. Pammolli, 2008, "Size dependent standard deviation for growth rates: Empirical results and theoretical modelling", (with B. Podobnik, D. Horvatic, F. Wang, H. E. Stanley, and I. Grosse), Physical Review E, 77(1)

- F. Pammolli, 2008, "On the Size Distribution of Business Firms", (with J. Growiec, M. Riccaboni, H.E. Stanley), Economics Letters, 98(2), 207-212

- F. Pammolli, 2008, "La Sanità in Italia - Federalismo, regolazione dei mercati, sostenibilità delle finanze pubbliche", (with N. C. Salerno), Il Mulino, Bologna

- F. Pammolli, 2008, "Il sistema pensionistico: quale riforma?", (with N. C. Salerno), parte
II, cap.9, pp. 335 – 353 in: A cura di Luciano Guerzoni, La Riforma del Welfare - Dieci anni dopo la «Comissione Onofri», Il Mulino, Bologna

- F. Pammolli, 2008, "I livelli essenziali di assistenza, la regolazione e la riforma multipilastro", (with N. C. Salerno, G. Turchetti), parte IV, cap. 2, pp. 263-292 in A cura di Antonio Pedone, La Sanità in Italia - Qualità del servizio e sostenibilità finanziaria, Edizioni Il Sole 24 ORE, Milano

- F. Pammolli, 2008, "Patent Value and R&D Competition", (with L. Magazzini, M. Riccaboni), working paper

- F. Pammolli, 2008, "Regolazione di prezzo, innovazione e ciclo di vita dei prodotti: per una riforma del sistema di pricing nel settore farmaceutico", (with C. Bonassi, M. Riccaboni, N.Salerno), cap. III, pp 79-132 in "La salute e il mercato. La ricerca farmaceutica tra Stato, industria e cittadini", a cura di Giorgio Macciotta, collana Ricerche di Astrid, Il Sole 24 ORE, Milano

- F. Pammolli, 2008, "La distribuzione al dettaglio dei farmaci: tra regolazione efficiente e mercato", (with N.Salerno), cap. VI, pp 153-198 in "La salute e il mercato. La ricerca farmaceutica tra Stato, industria e cittadini", a cura di Giorgio Macciotta collana Ricerche di Astrid, Il Sole 24 ORE, Milano

- F. Pammolli, 2008, "Who's Doing What in Pharmaceutical R&D?", (with L. Magazzini, M. Riccaboni), working paper

- F. Pammolli, 2007, "The Growth of Business Firms: Facts and Theory", (with S. V. Buldyrev, J. Growiec, M. Riccaboni, H. E. Stanley), Journal of the European Economic Association, 5(2/3), 574–584

- F. Pammolli, 2007, "Betweennes Centrality of Fractal and Non Fractal Scale Free Model Networks and Tests on Real Networks", (with M. Kitsak, S. Havlin. G. Paul, M. Riccaboni, H. E. Stanley), Physical Review E, 75(5)

- F. Pammolli, 2007, "Innovation and Industrial Leadership: Lessons from Pharmaceuticals", (with M. Riccaboni), Center for Transatlantic Relations, The Johns Hopkins Universitiy, Washington D.C.

- F.Pammolli, 2007, "Health Services in an Open Transatlantic Market: A European Perspective" (with M. Riccaboni, C. Bonassi), cap. IV, pp 77-97 in "Sleeping Giant – Awakening The Transatlantic Services Economy", edited by Daniel S. Hamilton and Joseph P. Quinlan, Center for Transatlantic Relations, The Johns Hopkins University, Washington D.C.

- F. Pammolli, 2007, "Politiche di liberalizzazione e concorrenza in Italia", (with C. Cambini, A. Giannaccari), Il Mulino – Prismi, Bologna

- F. Pammolli, 2007, "Introduzione. Liberalizzazioni e concorrenza in Italia", (with C. Cambini, A. Giannaccari), pp. 7-26 in F. Pammolli, C. Cambini, A. Giannaccari, Politiche di liberalizzazione e concorrenza in Italia., Il Mulino – Prismi, Bologna

- F. Pammolli, 2007, "Il settore farmaceutico tra barriere alla concorrenza e regolazione sul lato del consumo" (with M. Riccaboni, N. Salerno), cap. XI, pp. 325-350 in F. Pammolli, C. Cambini, A. Giannaccari, Politiche di liberalizzazione e concorrenza in Italia., Il Mulino – Prismi, Bologna

- F. Pammolli, 2007, "Spesa sanitaria, demografia, istituzioni", cap. 7, pp. 103-125 in A cura di M. Madìa, introduzione di E. Letta, Un Welfare Anziano - Invecchiamento della popolazione o ringiovanimento della società?, Il Mulino – Arel, Bologna

- F. Pammolli, 2007, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment", (with S.V. Buldyrev, M. Riccaboni, K. Yamasaki, D. Fu, K. Matia, H.E. Stanley), The European Physical Journal B, 57(2), 131–138

- F. Pammolli, 2007, "A Generalized Preferential Attachment Model for Business Firms Growth Rates. I. Empirical Evidence", (with D. Fu, S.V. Buldyrev, M. Riccaboni, K. Matia, K. Yamasaki, H.E. Stanley), The European Physical Journal B, 57 (2), 127–130

- F. Pammolli, 2006, "Il sistema di istruzione italiano: un confronto internazionale", (with G. Papa, N.C. Salerno), vol. 13, parte I, cap. 4, pp. 81-125 in A cura di Paola Reggiani Gelmini, Michele Tiraboschi, Prefazione di Letizia Moratti, Scuola, Università e Mercato del lavoro dopo la Riforma Biagi - Le politiche per la transizione dai percorsi educativi e formativi al mercato del lavoro, Collana Adapt - Fondazione "Marco Biagi", Giuffré Editore, Milano

- F. Pammolli, 2006, "Preferential Attachment and Growth Dynamics in Complex Systems", (with K. Yamasaki, K. Matia, D. Fu, S. V. Buldyrev, M. Riccaboni, H. E. Stanley), Physical Review E, 74, 3, 035103(R)8

- Commission on Intellectual Property Rights, Innovation and Public Health, 2006, " Public Health, Innovation and Intellectual Property Rights", World Health Organization, Geneva, Switzerland.
The report is available at: http://www.who.int/intellectualproperty/report/en/

- F. Pammolli, 2005, "Nuove Imprese, Concorrenza e Produttività", Le nuove imprese in Italia 1998-2002:Osservatorio Unioncamere sulla Demografia delle Imprese, Franco Angeli, 2005

- F. Pammolli, 2005, "Intellectual Property, Technological Regimes and Market Dynamics", (with M. A. Rossi), Economia e Politica Industriale, 2/2005

- F. Pammolli, 2006, "Growth and Diversification Patterns of the Worldwide Pharmaceutical Industry", (with Giulio Bottazzi and Angelo Secchi), in G. Dosi e M. Mazzucato (eds), Knowledge Accumulation and Industry Evolution. The Case of Pharma-Biotech, Cambridge University Press, Cambridge, UK, pp. 208-233

- F. Pammolli, 2005, "The Growth of Business Firms: Theoretical Framework and Empirical Evidence", (with D. Fu, S.V. Buldyrev, M. Riccaboni, K. Yamasaki, K. Matia, H.E. Stanley) Proceedings of the National Academy of Sciences, 102(52), 18801-18806 (cover article)

- F. Pammolli, 2005, "Economic Evaluation of HIV Treatments: The I.CO.N.A. Cohort Study", (with M. Merito, A. Bonaccorsi, M. Riccaboni, G. Baio, C. Arici, A. D'Arminio Monforte, P. Pezzotti, D. Corsini, A. Tramarin, R. Cauda, V. Colangeli, G. Pastore), Health Policy, 74(3), 304-313

- F. Pammolli, 2005, Medical Devices Competitiveness and Impact on Public Health Expenditure, (with M. Riccaboni, C. Oglialoro, L. Magazzini, N. Salerno, G. Baio), Entreprise Directorate-General, European Commission, Bruxelles

- F. Pammolli, 2005, "Pharmaceuticals Analysed through the Lens of a Sectoral Innovation System", (with M. McKelvey, L. Orsenigo), Part II.3 in F. Malerba (Ed.), Sectoral Systems of Innovation. Concepts, Issues and Analyses of Six Major Sectors in Europe, Cambridge University Press

- F. Pammolli, 2005, Modelli e Strategie di Marketing, Franco Angeli, Milano

- F. Pammolli, 2004, Sicurezza, Innovazione, Crescita, (with A.Paci, M. Riccaboni ), Il Mulino, Bologna

- F. Pammolli, 2004, "Statistical Properties of Business Firm Structure and Growth", (with K. Matia, D. Fu, S. V. Buldyrev, M. Riccaboni), Europhysics Letters, 67(3), 493-503

- F. Pammolli, 2004, "Market Structure and Drug Innovation ", (with M. Riccaboni), Health Affairs, 23(1), 48-50

- F. Pammolli, 2004, "The Nature and Extent of the Market for Technology in Biopharmaceuticals" (with A. Arora, A. Gambardella, M. Riccaboni), Part 2, pp. 175-202, in F. Cesaroni, A. Gambardella e W. Garcia-Fontes (Eds.), R&D, Innovation and Competitiveness in the European Chemical Industry, Springer, Dordrecht, NL

- F. Pammolli, 2004, "Dynamic Competition in Pharmaceuticals: On Patent Expiry, Generic Penetration and Industry Structure", (with L. Magazzini, M. Riccaboni), European Journal of Health Economics, 5(2), 175-182

- F. Pammolli, 2004, "Technological Competencies in Networks of Innovators", (with M. Riccaboni), Chap. 6 in J. Cantwell, A. Gambardella, O. Granstrand (Eds.) The Economics and Management of Technological Diversification, Routledge, London, UK

- F. Pammolli, 2003, "On Size and Growth of Business Firms", (with G. De Fabritiis, M. Riccaboni) Physica A, 324(1-2), pp. 38-44

- F. Pammolli, 2003, "Technological Regimes and the Evolution of Networks. Lessons from Biotechnology and Pharmaceuticals", (with M. Riccaboni), International Journal of Technology Management, 25(3/4), pp. 334-349

- F. Pammolli, 2003, "Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry", (with M. Riccaboni), Chap. 2 in P. P. Saviotti (Ed.), Applied Evolutionary Economics: New Empirical Methods and Simulation Techniques, Edward Elgar, Cheltenham

- F. Pammolli, 2003, "Public Research and Industrial Innovation: A comparison of U.S. and European Innovation Systems in the Life Sciences", (with J. Owen-Smith, W.W. Powell, M. Riccaboni), Chap. 10 in A. Geuna, A. Salter, E. Steinmueller, (Eds.), Science and Innovation: Rethinking the Rationales for Funding and Governance, Edward Elgar, Cheltenham

- F. Pammolli, 2002, "Innovation and Competitiveness in European Biotechnology", (with A. Allansdottir, A. Bonaccorsi, A. Gambardella, M. Mariani, L. Orsenigo, , M. Riccaboni), Enterprise Papers n. 7, Enterprise Directorate-General, European Commission, Bruxelles.
The paper is also available at: http://ec.europa.eu/enterprise/library/enterprise-papers/pdf/enterprise_paper_07_2002.pdf

- F. Pammolli, 2002, "Technological Regimes and the Growth of Networks: An Empirical Analysis", (with M. Riccaboni), Small Business Economics, 19(3), 205-215

- F. Pammolli, 2002, "The Intensity of Competition after Patent Expiry in Pharmaceuticals: a Cross-country Analysis", (with L. Magazzini, L.Orsenigo), Revue d'Economie Industrielle, 99, 107-132

- F. Pammolli, 2002, "A Comparison of U.S. and European University-Industry Relations in the Life Sciences", (with J. Owen-Smith, W.W. Powell, M. Riccaboni), Management Science, 48(1), 24-43. Also in M. McKelvey & L. Orsenigo (Eds.), The Economics of Biotechnology, Volume II, 342-361, Edward Edgar, Cheltenham

- F. Pammolli, 2002, "On Firm Growth in Networks", (with M. Riccaboni), Research Policy, 31(8-9), 1405-1416

- F. Pammolli, 2002, "Europe and the United States: The Power of Networks. Lessons from Technology Transfer", (with J. Owen-Smith, , W.W. Powell, M. Riccaboni ), Biofutur, 222, 26-29

- F. Pammolli, 2001, "The Nature and the Extent of Markets for Technology", (with A. Arora, A. Gambardella, M. Riccaboni), CNRS, Collection Les Cahiers de l'Innovation, Cahier n. 37

- F. Pammolli, 2001, "Innovation and Corporate Growth in the Evolution of the Drug Industry", (with G. Bottazzi, G. Dosi, M. Lippi, , M. Riccaboni), International Journal of Industrial Organization, 19 (7), 1161-1187

- F. Pammolli, 2001, "Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry", (with L. Orsenigo, M. Riccaboni), Research Policy, 30(3), 485-508. Also in M. McKelvey & L. Orsenigo (Eds.), The Economics of Biotechnology, Volume II, 172-198, Edward Edgar, Cheltenham, UK

- F. Pammolli, 2001, "Variety and Irreversibility in Scientific and Technological Systems: the Evolution of an Industry Network", (with L. Orsenigo, M. Riccaboni), in A. Nicita, U. Pagano (Eds.), The Evolution of Economic Diversity, Routledge, London, 216-239

- F. Pammolli, 2001, "Global Competitiveness in Pharmaceuticals: A European Perspective" (with A. Gambardella, L. Orsenigo), DG Enterprise, European Commission, 2001.